Antiobiotics Flashcards
(117 cards)
which drugs inhibit cell wall synth?
Vancomycin, Bacitracin, Penicillins, Cephalosporins, carbapenems
Ampicillin
Aminopencillin
extended spectrum, often administered with B-lactamase inhibitor
Gram +: streptococcus and staphylococcus (not MRSA)
Gram -: H. influenza, E. Coli, Proteus miribalis
Randoms: Listeria monocytogenes
Use: upper resp. tract infections (of S. pyogenes, S. pneumoniae, H. influenzae), sinusitis, otitis media, enterococcal infections
Amoxicillin
Aminopenicillin - just PO
extended spectrum, often administered with B-lactamase inhibitor
Gram +: streptococcus and staphylococcus (not MRSA)
Gram -: H. influenza, E. Coli, Proteus miribalis
Randoms: Listeria monocytogenes
Use: upper resp. tract infections (of S. pyogenes, S. pneumoniae, H. influenzae), sinusitis, otitis media, enterococcal infections
Piperacillin
Anti-Psudeomonal penicilin
Extended spectrum:
Gram pos: streptococcus and staphylococcus (not MRSA)
Gram negs: H. influenza, E. Coli, Proteus miribalis
Randoms: Listeria monocytogenes
And Extended to more serious gram negatives:
- to Pseudomonas aeruginosa, Enterobacter, and Proteus spp
Therapeutic use: serious gram-negative infections, hospital acquired pneumonia (HAP), immunocompromised patients, bacteremia, burn infections, UTI
.
Cefriaxone
third gen. cephalosporin
Less active against gram positive, but more active against gram negatives.
** active against Enterobacteriaceae (i.e. Klebsiella pneumonia, proteus mirabalis, providencia, serratia) and Haemophilus influenza
Therapeutic use:
DOC for for serious gram-negative infections (Klebsiella, Enterobacter, Proteus, Providencia, Serratia, Haemophilus),
- Ceftriaxone DOC for all forms of gonorrhea and severe Lyme’s disease, meningitis
Ceftazidime
third gen. cephalosporin
Less active against gram positive, but more active against gram negatives.
- active against Enterobacteriaceae (i.e. Klebsiella pneumonia, proteus mirabalis, providencia, serratia) and Haemophilus influenza
- ** ACTIVE AGAINST PSEUDOMONAS **
Use:
DOC for for serious gram-negative infections (Klebsiella, Enterobacter, Proteus, Providencia, Serratia, Haemophilus)
- Ceftazidime covers Pseudomonas
Cefepime
Fourth generation Cephalosporin
Spectrum: extends beyond third-generation (some gram +, enterobacteria gram negs), useful in serious infections in HOSPITALIZED PATIENTS. Effective against Pseudomonas
Therapeutic use: empirical treatment of nosocomial infections (infections aqd in hospital)
meropenem
carbapenem
- Very broad spectrum
Covers: aerobic and anaerobic, gram positives, Enterobacteriaceae, Pseudomonas, Acinetobacter
Therapeutic use: UTI, lower respiratory tract infection (LRTI), intra-abdominal, gynecological, SSTI, bone and joint infections – very broad spectrum, should be used VERY sparingly, only In very serious infections!!!
Ertapenem
carbapenem
- Very broad spectrum
Covers: aerobic and anaerobic, gram positives, Enterobacteriaceae, Pseudomonas, Acinetobacter
Therapeutic use: UTI, lower respiratory tract infection (LRTI), intra-abdominal, gynecological, SSTI, bone and joint infections – very broad spectrum, should be used VERY sparingly, only In very serious infections!!!
ampicillin-sublactam
B-lactamase inhibitor
MOA: prevent destruction of B-lactam antibiotics
S. Serratia spp P. Pseudomonas aeruginosa I. Indole + (Acinetobacter, Morganella, Proteus [not mirabilis]) C. Citrobacter spp E. Enterobacter cloacae
amoxicillin-clavulanic acid
B-lactamase inhibitor
MOA: prevent destruction of B-lactam antibiotics
S. Serratia spp P. Pseudomonas aeruginosa I. Indole + (Acinetobacter, Morganella, Proteus [not mirabilis]) C. Citrobacter spp E. Enterobacter cloacae
Piperacillin-tazobactam
B-lactamase inhibitor
MOA: prevent destruction of B-lactam antibiotics
S. Serratia spp P. Pseudomonas aeruginosa I. Indole + (Acinetobacter, Morganella, Proteus [not mirabilis]) C. Citrobacter spp E. Enterobacter cloacae
Vancomycin
glycopeptide
MOA: inhibits cell wall synthesis binding with high affinity to D-Ala-D-Ala terminal of cell wall precursor units
Spectrum: broad gram-positive coverage
S. aureus (including MRSA), S. epidermidis (including MRSE), Streptococci, Bacillus, Corynebacterium spp, Actinomyces, Clostridium
Therapeutic use: osteomyelitis, endocarditis, MRSA, Streptococcus, enterococci, CNS infections, bacteremia, orally for Clostridium difficile (only oral indication for Vanc)
ciproflaxacin
fluoroquinolone
MOA: targets bacterial DNA gyrase & topoisomerase IV. Prevents relaxation of positive supercoils
Spectrum: E. coli, Salmonella, Shigella, Enterobacter, Campylobacter, Neisseria, Pseudomonas aeruginosa, S. aureus (not MRSA), limited coverage of Streptococcus spp.
Therapeutic use: UTI, prostatitis, STI (chlamydia, Neisseria gonorrhoeae), traveler’s diarrhea, shigellosis, bone, joint, SSTI infections, diabetic foot infections
Levoflaxacin
Fluoroquinolone
MOA: targets bacterial DNA gyrase & topoisomerase IV. Prevents relaxation of positive supercoils
Spectrum: E. coli, Salmonella, Shigella, Enterobacter, Campylobacter, Neisseria, Pseudomonas aeruginosa, S. aureus (not MRSA), limited coverage of Streptococcus spp.
Therapeutic use: UTI, prostatitis, STI (chlamydia, Neisseria gonorrhoeae), traveler’s diarrhea, shigellosis, bone, joint, SSTI infections, diabetic foot infections
Moxifloxacin
Fluoroquinolone
MOA: targets bacterial DNA gyrase & topoisomerase IV. Prevents relaxation of positive supercoils
Spectrum: E. coli, Salmonella, Shigella, Enterobacter, Campylobacter, Neisseria, Pseudomonas aeruginosa, S. aureus (not MRSA), limited coverage of Streptococcus spp.
** this one is metabolized by the liver, so it does not need to be dose adjusted for those with renal failure!
Therapeutic use: UTI, prostatitis, STI (chlamydia, Neisseria gonorrhoeae), traveler’s diarrhea, shigellosis, bone, joint, SSTI infections, diabetic foot infections
Gentamicin
Aminoglycoside
MOA: binds 30S
Spectrum: aerobic gram-negative bacteria, limited action against gram-positive, synergistic bactericidal effects in gram-positive with cell wall active agent (like Beta lactam or Vanc)
Therapeutic use: UTI (not uncomplicated), used if resistance to other agents, seriously ill patients, pneumonia (infective against S. pneumoniae and anaerobes), HAP, peritonitis, synergy in bacterial endocarditis, tobramycin inhalation in CF
Doxycycline
tetracycline/glycylcylclines
Spectrum: wide range of aerobic/anaerobic gram + and gram - (as well as Rickettsia, Coxiella burnetii, Mycoplasma pneumoniae, Chlamydia spp, Legionella, atypical mycobacterium, Plasmodium, Borrelia burgdorferi (Lyme’s disease), Treponema pallidum (syphilis)
** Pseudomonas not covered ***
Therapeutic use: CAP, atypical CAP coverage, community acquired SSTIs, community acquired MRSA, acne, Rickettsial infections (Rocky Mountain Spotted Fever), Q fever, anthrax
Azithromycin
macrolide/ketolide
MOA: inhibits translocation of 50s subunit
Use: : respiratory tract infections (due to coverage of S. pneumoniae, H. influenzae, and atypicals: Mycoplasma, Chalmydophilia, Legionella), alternative for otitis media, sinusitis, bronchitis, and SSTIs. Pertussis, gastroenteritis, H. pylori, Mycobacterial infections
Clindamycin
Lincosamide
MOA: binds 50S subunit
Spectrum: pneumococci, S. pyogenes, viridans Streptococci, MSSA, anaerobes (B. fragilis)
(all gram negs are resistant)
Use:
SSTIs, necrotizing SSTIs, lung abscesses, anaerobic lung and pleural space infections, topically for acne vulgaris
Linezolid
oxazalidinone:
MOA: inhibits synth binding P site of 50S
Spectrum: : gram-positive Staphylococcus (MSSA, MRSA, VRSA), Streptococcus (penicillin resistant S. pneumoniae), enterococci (VRE), gram-positive anaerobic cocci, gram-positive rods (Corynebacterium, L. monocytogenes)
Use: VRE faecium (SSTI, UTI, bacteremia), nosocomial pneumonia caused by MSSA and MRSA, CAP, complicated/uncomplicated SSTI infections
Oseltamivir
Antiviral- “Tamiflu”
Flucanazole
Antifungal
Itraconazole
Antifungal